Brief Article
Copyright ©2014 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Clin Cases. Mar 16, 2014; 2(3): 52-56
Published online Mar 16, 2014. doi: 10.12998/wjcc.v2.i3.52
Retrospective chart review of skin cancer presence in the wide excisions
Ye Yuan, Michelle L Duff, Dawn L Sammons, Shiyong Wu
Ye Yuan, Shiyong Wu, Edison Biotechnology Institute and Department of Chemistry and Biochemistry, Ohio University, Athens, OH 45701, United States
Michelle L Duff, Dawn L Sammons, Department of Specialty Medicine, Heritage College of Osteopathic Medicine, Ohio University, Athens, OH 45701, United States
Author contributions: Sammons DL initiated the project; Sammons DL and Wu S designed the report; Duff ML extracted the data; Yuan Y analyzed the data and organized the results; Wu S, Duff ML and Yuan Y wrote the paper.
Supported by NIH RO1CA086928 to Wu S; and Graduate assistantship to Yuan Y from the Department of Chemistry and Biochemistry, Ohio University
Correspondence to: Dawn L Sammons, DO, Assistant Professor, Department of Specialty Medicine, Heritage College of Osteopathic Medicine, Ohio University, Athens, 75 Hospital Drive, Athens OH, 45701, United States. drdawn@oakviewderm.com

Telephone: +1-740-5664621
Received: October 11, 2013
Revised: February 18, 2014
Accepted: February 20, 2014
Published online: March 16, 2014
Abstract

AIM: To investigate cancer cell absence or presence in wide excision after biopsy of squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) patients.

METHODS: 200 patients (100 BCC and 100 SCC) from the same dermatology clinic, who had positive margin upon biopsy, were selected from a computer generated randomized report. All selected patients had wide excision following biopsy. To determine the correlation of gender, age distribution and cancer absence, BCC and SCC cases were separated based on excision-cancer absent or present after wide excision. χ2 tests, Fisher’s exact tests were used to analyze the ratio of male to female between excision-cancer absent and excision-cancer present patients, while Mann-Whitney U test were used to compare the age distribution in the two groups. Statistical analyses were performed using SPSS version 16.0 for Windows.

RESULTS: Our retrospective chart review of the patients showed that cancer cells were absent in 49% of BCC patients (n = 100) and 64% of SCC patients (n = 100) who had previously had positive margins upon biopsy. Gender analysis showed the ratio of male to female (M/F) in the BCC arm was significantly higher compared with the SCC arm in those with excision-cancer absent (2.06 vs 0.66; P = 0.004; χ2 test). But M/F of excision-cancer absent and excision-cancer present in neither BCC nor SCC patients was statistically significant. Age adjustment showed no significant difference between excision-cancer absent and excision-cancer present in BCC and SCC patients. Nevertheless, in excision-cancer absent cases, the age distribution showed that the BCC patients were younger than SCC patients (average age 67 vs 74; P < 0.001; Mann-Whitney U test). In addition, our data also indicated that in the patient group of 71-80 years old, there were more SCC patients who showed excision-cancer absence (67.6% vs 39.4%; P = 0.02; χ2 test).

CONCLUSION: Our study indicates that approximately 50% or more of BCC and SCC patients with positive margins found on biopsies did not have cancer cells present at the time of wide excisions.

Keywords: Biopsy, Histology, Positive margin, Skin cancer, Wide excision

Core tip: Wide excisions are performed for skin cancers when malignant cells extend to the margins of biopsy. It is expected that cancer cells will appear in the excised tissue at the time of wide excision. However, an analysis of wide excision tissue samples from 200 patients revealed that approximately 50% or more basal and squamous cell carcinoma patients with cancer cells that extended to the margins in biopsy did not have cancer cells present on wide excision. This finding suggests that the wound caused by the biopsy itself may trigger a body response to eliminate cancer cells.